Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • Medical Devices (& Hospital Services) |
Stages | Seed, Startup, Early Stage, Expansion, Later Stage |
Investing | United States • Canada • Europe |
Investment Range | $250,000 - $25,000,000 |
Assets Under Management | $900,000,000 |
Prospect Capital Management (PCM) is an established private equity firm that focuses on leveraging its significant assets under management, totaling approximately $900 million, to make strategic investments across various industries. Since its inception in 1988, PCM has honed its expertise in private equity investments, particularly in the fields of BioTech, Medical Devices (& Hospital Services), and has extended its reach to business services, food, consumer products, healthcare, consumer services, industrials, energy, manufacturing, financial services, and media sectors. Headquartered on the 42nd Floor of 10 East 40th Street in New York, PCM prides itself on a flexible investment approach, offering seed capital to later-stage development with an investment range between $250,000 and $25,000,000. Their investment solutions spread across credit, private equity, and real estate markets, enabling them to provide a diverse array of avenues for capital growth and investments. PCM operates as the investment advisor to Prospect Capital Corporation and has maintained a prominent position as a leading alternative investment manager by providing innovative investment solutions that cater to the evolving demands and opportunities within the market. Their experience and longstanding presence in the industry allow them to identify and capitalize on unique opportunities, delivering strong returns to their investors while also contributing to the growth and development of their portfolio companies.